Since the thioredoxin system is overexpressed in tumor cells, its inhibition appears as a promising therapeutic strategy to increase ROS levels and oxidative stress and induce GBM cell apoptosis (Nordberg et al., 2001; Watson et al., 2004; Branco et al., 2020). The gene discussed is TXN; the disease is neoplasm.